PPAR Agonists in Primary Biliary Cholangitis

被引：10
|
作者：
Schnabl, Bernd [1 ]
机构：
[1] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2024年 / 390卷 / 09期
关键词：
PLACEBO-CONTROLLED TRIAL;
D O I：
10.1056/NEJMe2313802
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Activating PPARs to Treat Primary Biliary Cholangitis This editorial describes the science behind clinical trials testing elafibranor and seladelpar in the treatment of primary biliary cholangitis.
引用
收藏
页码：855 / 858
页数：4
相关论文
共 50 条
  • [1] PPAR agonists for primary biliary cholangitis
    Gossard, Andrea A.
    Gores, Gregory J.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (10): : 693 - 694
  • [2] Revisiting PPAR agonists: novel perspectives in the treatment of primary biliary cholangitis
    Chen, Yiran
    Zheng, Kunyu
    Da, Gahu
    Wang, Xu
    Wei, Yi
    Wang, Guochun
    Zhang, Fengchun
    Wang, Li
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (13) : 1825 - 1834
  • [3] PPAR agonists for the treatment of primary biliary cholangitis: Old and new tales
    Colapietro, Francesca
    Gershwin, M. Eric
    Lleo, Ana
    JOURNAL OF TRANSLATIONAL AUTOIMMUNITY, 2023, 6
  • [4] PPAR Agonist effective in primary biliary Cholangitis
    Kessing, Richard
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2024, 62 (08): : 1189 - 1190
  • [5] Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor Agonists
    Abenavoli, Ludovico
    Procopio, Anna Caterina
    Fagoonee, Sharmila
    Pellicano, Rinaldo
    Carbone, Marco
    Luzza, Francesco
    Invernizzi, Pietro
    DISEASES, 2020, 8 (02)
  • [6] Investigational farnesoid X receptor agonists for the treatment of primary biliary cholangitis
    Akepati, Prithvi Reddy
    Gochanour, Eric M.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024, 33 (06) : 627 - 638
  • [7] Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
    Yokoda, Raquel T.
    Carey, Elizabeth J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (10): : 1593 - 1605
  • [8] Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
    Sarcognato, Samantha
    Sacchi, Diana
    Grillo, Federica
    Cazzagon, Nora
    Fabris, Luca
    Cadamuro, Massimiliano
    Cataldo, Ivana
    Covelli, Claudia
    Mangia, Alessandra
    Guido, Maria
    PATHOLOGICA, 2021, 113 (03) : 170 - 184
  • [9] Suppression of Hepatic PPARα in Primary Biliary Cholangitis Is Modulated by miR-155
    Adamowicz, Monika
    Kempinska-Podhorodecka, Agnieszka
    Abramczyk, Joanna
    Banales, Jesus M.
    Milkiewicz, Piotr
    Milkiewicz, Malgorzata
    CELLS, 2022, 11 (18)
  • [10] Primary Biliary Cholangitis
    Andrew R. Scheinberg
    Cynthia Levy
    Current Treatment Options in Gastroenterology, 2022, 20 (3) : 469 - 483
12345